The global pharmaceutical cartridges market size is anticipated to reach USD 2.43 billion by 2030 and is anticipated to expand at a CAGR of 8.07% from 2024 to 2030. The market is driven by various factors such as rapid growth in the pharmaceutical industry, increasing use of self-administered medications, and rising demand for wearable injectors.
Wearable injectors are designed for dispensing substantial drug volumes over prolonged periods and frequently employ pre-filled cartridges for containment and administration of medications. This trajectory in technology amplifies the need for pharmaceutical cartridges tailored to meet the distinctive demands of wearable injector systems. Such cartridges provide exact dosing precision, assure compatibility with diverse drugs, and sustain the stability of medications throughout extended durations. Pharmaceutical companies and manufacturers are progressively prioritizing the development of pharmaceuticals compatible with wearable injectors. This trend has led to heightened demand for specialized cartridges tailored to meet the distinctive specifications of these advanced drug delivery systems.
For instance, in October 2023, Enable Injections revealed the FDA approval for its innovative wearable injector, Empaveli Injector. This advanced wearable device is specifically designed for the adult demographic with paroxysmal nocturnal hemoglobinuria. It offers a hands-free drug delivery mechanism, accommodating a volume of up to 25 ml. Its versatile design facilitates utilization both within the confines of one's home and in clinical settings. This regulatory endorsement underscores the device's efficacy and safety, significantly empowering individuals grappling with paroxysmal nocturnal hemoglobinuria through enhanced and convenient therapeutic interventions. The intersection of patient-centric drug delivery solutions, technological advancements, and the rising prevalence of wearable injectors is molding the landscape of pharmaceutical industry.
As pharmaceutical companies and cartridge manufacturers realign their strategies to adapt to changing demands of healthcare delivery, the market is set for sustained growth, presenting abundant prospects for innovation and collaboration in this dynamic and transformative sector. Additionally, the convergence of digital health technologies with wearable injectors is further amplifying the demand for smart cartridges capable of integrating with electronic systems to enhance monitoring, adherence, and overall patient outcomes thus propelling the industry growth.
Request a free sample copy or view report summary: Pharmaceutical Cartridges Market Report
Plastic cartridges segment is expected to register the fastest CAGR of 8.93% during the forecast period. Plastic is preferred for packaging solutions due to its favorable characteristics, including low weight, malleability, and cost-effectiveness, in comparison to metal and glass
Wearable injectors segment is expected to register the fastest CAGR of 9.33% during the forecast period. This is due to the growing preference for homecare settings and advancements in drug delivery technologies
Dual chamber segment is expected to register the fastest CAGR of 8.61% during the forecast period owing its ability to enhance the shelf life and efficacy of sensitive biologics and complex drug formulations
3ml segment is expected to register the fastest CAGR of 9.26% during the forecast period. Pharmaceutical companies are increasingly developing drugs tailored to individual patient needs, and 3ml cartridge size provides a versatile option for accommodating varying dosage requirements
Diabetes segment is expected to register the fastest CAGR of 9.69% during the forecast period. Increasing incidence of diabetes coupled with rising geriatric population drive the segment growth
Others end-use segment is expected to register the fastest CAGR of 9.61% during the forecast period. Other end-users segment includes life sciences companies, academic institutes, and drug product/ fill & finish contract manufacturers
North America dominated the pharmaceutical cartridges market in 2023 owing to the presence of majority of pharmaceutical companies manufacturing cartridges in this region
Grand View Research has segmented the global pharmaceutical cartridges market based on material type, application, chamber type, size, therapeutic area, end-use, and region:
Pharmaceutical Cartridges Material Type Outlook (Revenue, USD Million, 2018 - 2030)
Glass Cartridges
Type 1
Type 2
Type 3
Plastic Cartridges
Polypropylene (PP)
Cyclic Olefin Copolymer (COC)
Cyclic Olefin Polymer (COP)
Polyethylene
Rubber
Pharmaceutical Cartridges Application Outlook (Revenue, USD Million, 2018 - 2030)
Dental Anesthesia
Pen Injectors
Autoinjectors
Wearable Injectors
Pharmaceutical Cartridges Chamber Type Outlook (Revenue, USD Million, 2018 - 2030)
Dual Chamber
Large Volume
Pharmaceutical Cartridges Size Outlook (Revenue, USD Million, 2018 - 2030)
0.5 ml
1.8 ml
2ml to 2.5 ml
3 ml
5 ml
More than 10 ml
Pharmaceutical Cartridges Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
Ophthalmology
Respiratory
Neurology
Oncology
Immunology
Cardiology
Diabetes
Dental
Others
Pharmaceutical Cartridges End Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceuticals
Biotechnology
Research Organizations
Others
Pharmaceutical Cartridges Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of key players in the Pharmaceutical Cartridges Market
Stevanato Group
NIPRO
Gerresheimer AG
West Pharmaceutical Services, Inc.
Schott AG
Transcoject GmbH
Shandong Medicinal Glass Co., Ltd.
Dätwyler Holding Inc.
AptarGroup, Inc.
Sonata Rubber
"The quality of research they have done for us has been excellent..."